Founders Launch Sale — 40% OFF Limited to the first 100 customers Pre-order today to secure launch pricing All pre-orders will ship within 1 week once production and quality verification are complete Founders Launch Sale — 25% OFF Limited to the first 100 customers Pre-order today to secure launch pricing All pre-orders will ship within 1 week once production and quality verification are complete

Tesamorelin 10MG

Categories:

Tesamorelin 10MG is a synthetic peptide designed for research and laboratory use only. This compound selectively promotes lipogenesis, making it valuable in controlled scientific studies. It is important to note that this product is intended exclusively for research purposes and is not authorized for human or veterinary therapeutic applications. For research use only.

$89.99

COA

Secure
Payment

Third-party
Tested

⚠️ RESEARCH USE ONLY

This product is for R&D purposes only and is not approved for human or veterinary use.

Tesamorelin 10MG – Research-Use-Only Peptide

Tesamorelin 10MG

Tesamorelin is a synthetic peptide with selective growth hormone secretagogue activity, designed for scientific investigation within a research setting. This peptide is derived from the somatoliberin (GHRH) receptor agonist class, though it is not identical to endogenous growth hormone. Below are key aspects of its research relevance and context.

Research Context

Tesamorelin was originally developed to study its effects on lipolysis and visceral fat reduction in clinical and preclinical studies. Originally marketed as a pharmaceutical for the treatment of HIV-associated lipodystrophy, its research applications have expanded to include animal models for metabolic research, aging studies, and comparative pharmacological evaluations.

Research Overview

Tesamorelin acts by binding to growth hormone secretagogue receptors (GHS-R1a) in the hypothalamus, stimulating the release of growth hormone (GH) and insulin-like growth factor 1 (IGF-1). In research settings, its primary mechanisms of interest include fat tissue breakdown and metabolic adjustments in animal and possibly non-human primate models. Unlike GH itself, tesamorelin does not bind to GH receptors directly, offering a distinct research pathway.

Key Research Focus Areas

  • Metabolic and Lipid Profiling: Tesamorelin’s potential to enhance visceral fat reduction is a key focus, particularly in animal studies examining obesity-related metabolic changes.
  • Growth Hormone Dynamics: Research examines how tesamorelin modulates GH and IGF-1 secretion without inducing typical GH receptor-mediated effects, providing insights into its unique pharmacokinetics.
  • Comparative Pharmacology: Investigations compare tesamorelin’s effects to those of other GHRH agonists or GH itself, assessing its efficacy and safety in controlled experimental settings.
  • Aging and Longevity Studies: Emerging research explores tesamorelin’s potential role in age-related metabolic decline, though human studies remain limited in this context.

Important Disclaimer

This product is intended solely for academic or institutional research purposes and is not authorized for human or animal consumption. Users must adhere to all applicable laws, regulations, and ethical guidelines governing research materials. Misuse of peptides outside of designated research contexts may pose significant risks to health and may be subject to legal consequences. Consult with qualified researchers or regulatory bodies before handling or utilizing this substance.

For research use only. Not for human or animal consumption.

Size

10MG

Reviews

There are no reviews yet.

Be the first to review “Tesamorelin 10MG”

Your email address will not be published. Required fields are marked *

Related Products

Age Verification!

*By continuing, you confirm eligibility and legal compliance.